For healthcare, pharma and life sciences

Content marketing for healthcare, pharma and life sciences.

Your people already write more than almost anyone. The trouble is where: in journals, behind paywalls, for other researchers. Findwell takes the same expertise and puts it where a procurement lead, a clinician or an investor is actually looking.

IndustryHealth and life sciences
DeliveryBuilt and run by Profile

Two things that are usually bought separately, and that only work together.

A hub on a subdomain of your own site, with a page for each specialist built around the regulatory or clinical question they are trusted on, and the agency that writes and places it. It is the sector where credibility is everything and where almost nobody publishes under an individual's name.

What Findwell is

A content platform, and the agency that translates your experts.

The work

An agency that translates the science

We interview your clinicians and scientists, write in their voice, prepare it for medical and regulatory review, and pitch it out.

The place

A platform of your own to hold it

A hub on your subdomain with a page per specialist, structured so search and AI can read it.

Findwell

The platform, with the people who feed it

Live in about two weeks, on an hour a month from each specialist.

No IT projectRUNS ON A SUBDOMAIN
About 2 weeksTO GO LIVE
You own itCONTENT AND DOMAIN

What it actually is

One specialist, one page, and everything that comes off an hour of their time.

01

A page for the question they are trusted on.

Not a capabilities statement. The specialist's own page on your domain, about the regulatory or clinical question they are asked most, with their publications, comment and coverage gathered under it.

  • One question per specialist
  • Their expertise, in plain terms
  • Sourced on the page
experts.yourcompany.com / people / aisha-bello
Dr Aisha BelloHead of Regulatory Affairs, Medical Devices
SOFTWARE AS A DEVICEUK APPROVALAI IN HEALTH

When your software becomes a medical device

ARTICLE

Quoted in Med-Tech Innovation on AI rules

COVERAGE

Classification after the 2026 guidance

WEBINAR
02

One interview, and your review process intact.

We record the conversation, we draft in their voice, and put it through your own medical and regulatory review before anything appears. The process you already run is the process, not an obstacle we work round.

  • Your review, unchanged
  • Claims sourced as written
  • Nothing published unapproved
One hour, once a month
Recorded interviewDr Aisha Bello, 58 minutes
Their words, our writers.
From

When your software becomes a medical device

ARTICLE
From

Three posts in their own voice

SOCIAL
From

Ninety seconds to camera

VIDEO
From

A briefing they can send on

NEWSLETTER
03

Found before the submission is written.

Founders, regulatory leads and clinicians search the classification question long before they engage anybody. A page that answers it clearly is read at exactly the point a specialist is being chosen.

  • Written for the decision point
  • Specific to the regime
  • Ranking on your own domain
google.co.uk
What a founder searches before a submission2,100 a month across the cluster
when does software become a medical device
AllNewsForums

When your software becomes a medical device

experts.yourfirm.com

Classification after the 2026 guidance

experts.yourfirm.com

a regulator's guidance page

somebody else
04

And named when an assistant is asked instead.

Regulatory questions are increasingly put to an assistant instead, and search engines and answer engines cite whatever explained the rule best, so a named specialist gets cited where an organisation's overview page does not.

  • Cited by name
  • One page, both channels
  • Tracked monthly
AI answer

Is our clinical software a regulated device?

Classification turns on intended purpose rather than on the technology used. Dr Aisha Bello, who heads regulatory affairs for devices, has published a worked explanation of where the line falls.

Sourcesexperts.yourfirm.comthe trade press
05

And the reporting stands up to scrutiny.

There is a dashboard behind the hub: what each specialist ranks for, who is reading, and what the sector press picked up. Evidence rather than impressions, which is the only kind that survives a board.

  • By specialist and by question
  • Named organisations where allowed
  • Available on demand
experts.yourfirm.com / reporting
This monthSOFTWARE AS A DEVICE
34Keywords top 10
2,410Readers
11Named orgs

Software as a device

82%

Uk approval

56%

Ai in health

38%

What you get

Everything a specialist needs, made for them.

One conversation with a specialist turns into all of this. We make it, we take it through review, we place it, and every piece lands back on their own page.

Content strategyWhich specialists, which questions, and what medical and regulatory will clear. Agreed before anything is written, revisited quarterly.
Media articlesBylined pieces for HSJ, Pharmaphorum, Med-Tech Innovation and the nationals, pitched by our media team.
Articles for your hubThe cornerstone pieces that rank, on your own domain. A standing explanation of the evidence, not a press release about a preprint.
Social contentLinkedIn posts in the specialist’s own voice, which is where clinicians, investors and NHS procurement leads actually look.
NewslettersA briefing each specialist can send to their own network, a guidance change or a trial readout, from thinking already through review.
VideoNinety seconds of the specialist explaining what the evidence actually shows, to camera, filmed on the day of the interview.

Where we have experience

The areas we have published in.

6 areas we have already written, placed and ranked work in. The model is the same in each. What we publish is not.

Medtech and devices

We support clients in medtech and devices. The classification question is searched constantly and answered badly, so that is the standing guide we build first.

Pharma and biotech

We support clients in pharma and biotech. What can be said is tightly bounded, so we agree the boundary with your reviewers before we book the interview.

Digital health

We support clients in digital health. Your buyers are clinicians and commissioners rather than consumers, so nothing is written in consumer language.

Diagnostics

We support clients in diagnostics. The evidence is the argument, so the writing walks through the data rather than summarising a conclusion.

Clinical services

We support clients in clinical services. Referrers and commissioners search pathways, not providers, so the page answers the pathway question.

Providers

We support clients who are providers and groups. The reader is a commissioner with a spreadsheet, so we publish outcomes and process rather than a brand story.

Where we secure coverage for health and life sciences clients

HSJPharmaphorumPharmaTimesMed-Tech InnovationDigital HealthEndpoints NewsSTATScripNature BiotechnologyThe TimesFinancial TimesNew Scientist

The team behind it

You are hiring people, not software.

Findwell is a product of Profile, an award-winning thought leadership and PR agency. So is the team.

Jordan Greenaway
This is the only sector I work in where the expertise is already written down. It is in journals, behind paywalls, in a format built for reviewers rather than readers, and the person who needs it is a procurement lead with twenty minutes. Nobody has to become a writer here. Somebody just has to sit with the expert and ask what it means, then publish the answer where the question is actually being asked.

Jordan GreenawayFounder, Profile

Questions

What firms ask before they start.

+How much does content marketing for healthcare and life sciences cost?
From £1,000 per specialist per month. Where a company brings several people on at once that usually becomes a single collective retainer instead, covering the media relations, the video and the wider content across all of them, which works out lower per head. Six months is the minimum term, because nothing on a new hub has moved before then and neither of us would learn anything from a shorter run.
+Our people already publish in journals. Why is this different?
Because almost nobody who buys from you reads journals. The expertise already exists, it is peer reviewed and it is often excellent, and it sits behind a paywall in a format built for reviewers. This takes the same person and the same knowledge and answers the question a procurement lead, a clinician or an investor actually typed. It does not replace the paper. It is the thing that makes anyone outside the field aware the paper exists.
+How does this work with the ABPI Code?
It works within it rather than around it. Nothing we produce for a pharma client promotes a prescription medicine, and nothing goes near a product claim without medical and regulatory approval. Non-promotional, referenced, genuinely educational material from a named expert is permitted, and it is the space almost nobody occupies properly. Where a company is not authorised to sign something off, we work to whoever is.
+Can we talk about a product that is not approved yet?
Not as a product, and we would not try. What can be discussed is the problem, the evidence base, the regulatory pathway and the science, none of which requires a licence. In practice that is more useful anyway, because the audience searching at that stage is trying to understand the field rather than to buy anything.
+Is this SEO, AEO, GEO, PR or thought leadership?
All of them, which is the point. Answer engine optimisation and generative engine optimisation are new names for one old problem, which is being the source a system trusts enough to name. It matters here more than most, because when someone asks an assistant a health or regulatory question, the answer it gives is either grounded in a named expert or in whatever else it found. Underneath it is Person and Article markup on every page, one consistent byline per specialist and links out to their profiles and publications.
+Who writes it, and how much specialist time does it take?
We do. A recorded interview of about forty minutes, then fifteen minutes reviewing the draft. Roughly an hour a month, which is less than most people spend on a single conference abstract.

See what your specialists would rank for.

A thirty-minute walkthrough, on your own firm, of where your specialists sit today and what it would take to move them.

The rest of them

More industries.

Or see the whole platform on one page.

Book a demo

See it in action.

A 30-minute walkthrough, tailored to your firm.

The one-pager

Get the PDF.

A one-page overview you can forward to the rest of your team. Inside:

  • What your experts get, and how the hub is run for you
  • Where they get found, on Google and in AI answers
  • Example results and the timelines to expect
  • How pricing works, before you book a call